ArticleBMC public health2025
Barriers and enablers of adverse drug event reporting in South Africa: a cross-sectional survey of medicine users.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpontaneous reporting is the most frequently used method to collect data on adverse drug events (ADEs). To promote ADE reporting and enhance medicine safety, it is important to understand enablers and barriers to ADE reporting. This study described medicine users’ practices and previous experiences with reporting ADEs, including barriers and enablers to reporting ADEs in South Africa.
methodsThis was a cross-sectional, analytical study in which adults residing in South Africa were requested to complete an online questionnaire.
resultsThe majority of participants (70.5%, n = 203; N = 288) indicated that they experienced ADEs in the past and 77.0% (n = 181; N = 235) of these events occurred after the use of medication. Only 59.1% (n = 120; N = 203) of participants who experienced ADEs, reported them. There was no difference in reporting frequency between healthcare professionals (HCP) and non-HCPs (p > 0.9). Furthermore, 78.3% (n = 94; N = 120) of participants reported ADEs to their doctor. The main enabler for reporting ADEs indicated by both HCP and non-HCPs was that reporting could help to keep others safe. The most cited barrier to ADE reporting for both HCP and non-HCPs was the assumption that the side effects would go away once the medication was stopped.
conclusionsA large proportion of participants who experienced ADEs reported them to their doctors, and reporting of ADEs was similar between HCPs and non-HCPs. The barriers and enablers to reporting ADEs were similar for HCPs and non-HCPs. These results could help in planning awareness-raising campaigns aimed at improving ADE reporting in South Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.